Novo Nordisk has initiated a share repurchase programme in accordance with certain European regulations known as the Safe Harbour rules.
This programme is part of the overall share repurchase programme of up to EUR 2 billion to be executed during a year period starting from 3 February 2016.
Under the programme initiated 28 October 2016, Novo Nordisk will repurchase B shares for up to EUR 605 million from 28 October 2016 to 31 January 2017.